Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
Date:11/5/2012

engths of time or file additional lawsuits to defend its patent rights from challenges by companies that have submitted ANDAs for generic versions of OFIRMEV, and the substantial costs associated with such lawsuits; the potential introduction of generic competition to OFIRMEV in the event Cadence is unsuccessful in current or future patent litigation; Cadence's dependence on its licensors for the maintenance and enforcement of its intellectual property rights; the potential product liability exposure associated with pharmaceutical products such as OFIRMEV and other products Cadence may in-license or acquire; Cadence's ability to fully comply with numerous federal, state and local laws and regulatory requirements that apply to its commercial activities; public concern regarding the safety of drug products such as OFIRMEV, which could result in the implementation by regulatory agencies of new requirements to include unfavorable information in the labeling for OFIRMEV; the risk that Cadence may not be able to raise sufficient capital when needed, or at all; and other risks detailed under "Risk Factors" and elsewhere in Cadence's periodic reports and other filings made with the Securities and Exchange Commission from time to time. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995, and Cadence undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

Cadence® and OFIRMEV® are trademarks of Cadence Pharmaceuticals, Inc. Contact:

William R. LaRue

Kelli FranceSVP & Chief Financial Officer

Media RelationsCadence Pharmaceuticals, Inc.

WCGPhone: 858-436-1400

Phone:  415-946-1076 CADENCE PHARMACEUTICALS, INC.
CONDENSED STATEMENTS OF OPERATIONS
(unaudited)
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
2. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2012 Financial Results On August 2, 2012
3. Cadence Pharmaceuticals To Present At The Wedbush PACGROW Life Sciences Management Access Conference In New York City On August 14, 2012
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
5. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2012 Financial Results On November 5, 2012
6. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces ... Ltd., has received Chinese FDA (CFDA) approval and ... Tablets into the China ... and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., ... US FDA approved and China CFDA certified oral ...
(Date:8/20/2014)... WORTH, Fla. , Aug. 20, 2014  Glades Drugs, ... , is proud to announce its expansion into a ... , which will feature an 8,000-square-foot office space and state ... currently accepting applications for 100 open positions for the new ... at 4560 Lantana Road will serve as the chain,s corporate ...
(Date:8/20/2014)... -- Trovagene, Inc. (NASDAQ:   TROV), a developer of ... clinical studies will be presented at the 29th International ... for the detection of high risk strains of Human ... place in Seattle from August ... new U.S. patent was issued earlier this year for ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2Trovagene Provides Update on Its Urine-Based HPV Test 2Trovagene Provides Update on Its Urine-Based HPV Test 3
... , , , ... Exposure of Type I Diabetes Patients to Oramed,s Oral,Insulin and of a First-in-Humans Study With ... Oramed Pharmaceuticals, ... of the,American Diabetes Association currently being held in Orlando, Florida . Dr., Miriam Kidron ...
... WASHINGTON , June 28 Harris Corporation (NYSE: ... Inc., is helping to improve the quality of military patient ... Information Exchange (BHIE) interface.  The exchange is a health enterprise ... the Department of Veterans Affairs (VA) to securely share patient ...
Cached Medicine Technology:Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association 2Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association 3Harris Corporation Leverages CONNECT Solution to Enhance Patient Information Exchange Between DoD and VA 2
(Date:8/20/2014)... -- A group representing U.S. obstetricians is calling for ... According to the American College of Obstetricians and Gynecologists ... the safety and effectiveness of flu vaccination during pregnancy. ... be particularly dangerous to pregnant women, as it can ... Riley, chair of the college,s Immunization Expert Work Group, ...
(Date:8/20/2014)... the immune system is defective in people suffering from irritable ... ongoing issues with pain. , The research the first ... to explain why some painkillers may not offer satisfactory relief ... 10% of the community. There are different forms of ... often has the greatest impact on sufferers, quality of life. ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. 20, 2014 ... and other minor infections might trigger a strong but brief ... study suggests. Just five out of 100,000 children a ... Heather Fullerton, lead author of the study and a professor ... Francisco Benioff Children,s Hospital. "It seems infections play a role ...
(Date:8/20/2014)... The Board of Directors of top international ... pleased to announce the expansion of its healthcare ... and the surrounding region. In support of this strategic ... has relocated to the firm’s office in Shanghai, China, ... design and to better support regional clients. , ...
(Date:8/20/2014)... 20, 2014 With 3943.8% growth, Connexion Point ... the nation’s fastest growing companies. The Inc. 500 ranks Connexion ... sector. Connexion Point is the #1 fastest growing company in ... and Medicaid, and its clients include four of the top ... 1,000 people and has offices and contact centers in Salt ...
Breaking Medicine News(10 mins):Health News:All Pregnant Women Need Flu Shot: Ob/Gyn Group 2Health News:Pain treatments less effective for those with irritable bowel 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3Health News:With 3943.8% Growth, Connexion Point, a Leader in Contact Centers for Health Care, Ranks 86th on the Inc. 500 List as One of the Nation’s Fastest Growing Companies 2
... M.D., president and CEO of the Regenstrief Institute and ... University School of Medicine, received a 2011 Distinguished Investigator ... Education Meeting on April 28 in Washington, DC. ... and Contribution to Clinical and Translational Science. He is ...
... Australia and Europe. Large resources are set aside for research ... the research field is still new but researchers from ... years ago the Norwegian health care system had a low ... sectors", says Professor Karina Aase at the University of Stavanger. ...
... Injecting a tissue spacer in the prostate-rectal inter-space is ... prostate cancer patients receiving radiation therapy, according to research ... Radiation Therapy Symposium in Atlanta. This symposium is sponsored ... Radiological Society of North America (RSNA)., Even though prostate ...
... 3D models, produced by combining a patient,s CT scans ... planning. 3D printing technology is a fast ... planning. Radiologists are able to transform ultra high-resolution CT ... color printer commonly used in architecture, engineering and construction. ...
... HealthDay Reporter , THURSDAY, April 28 (HealthDay News) -- Men ... risk for developing potentially fatal blood clots, though overall the ... The researchers report that extra weight and extra inches together ... "Tall and obese men had more than a fivefold higher ...
... , THURSDAY, April 28 (HealthDay News) -- Two ... treated have been unanimously recommended for approval by a panel ... Drug Administration advisory committee voted 18-0 that telaprevir, made by ... high rate of rashes that has been reported among those ...
Cached Medicine News:Health News:Tierney named 2011 Clinical and Translational Research Distinguished Investigator 2Health News:Sustaining vulnerable lives 2Health News:Sustaining vulnerable lives 3Health News:Tissue spacers reduce risk of rectal injury for prostate cancer patients 2Health News:Tall, Obese Men More Prone to Leg Clots: Study 2Health News:New Hepatitis C Drugs Close to Gaining FDA Approval 2Health News:New Hepatitis C Drugs Close to Gaining FDA Approval 3
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
... The Self-Cath Closed System is a ... method for safe, simple catheterization designed ... tract infections. It includes a ... The new EasyOff tear tab makes ...
... Self-Cath family of 100% ... a variety of options ... Each catheter is made ... PVC and has smooth ...
... The Self-Cath family ... offers patients a variety ... self-catheterization. Each catheter ... medical grade PVC and ...
Medicine Products: